Advancing Value-Based Care: A Bipartisan Dialogue on Health Equity and Innovation 

Mr. Scully is a General Partner in the Healthcare Group, having joined WCAS in 2004. In addition to his portfolio companies, Mr. Scully also serves on the Board of Directors of the Health Management Academy, a strategic partner of WCAS that provides research, knowledge sharing and leadership development to leading US health systems. Before joining WCAS, he was the Administrator of the Centers for Medicare and Medicaid Services (CMS) for three years and the President and CEO of the Federation of American Hospitals for six years. He also served as the Deputy Assistant to the President and as the Associate Director of OMB under President GHW Bush from 1989 to 1993, and has practiced law at Alston and Bird; Patton Boggs; and Akin, Gump, Strauss Hauer and Feld. He is a Principal at the Lincoln Policy Group.

Education

Catholic University – J.D.

University of Virginia – B.A.

Mark McClellan, PhD is Director and Robert J. Margolis, M.D., Professor of Business, Medicine and Policy at the Duke-Margolis Institute for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence and more effective drug and device innovation. At the center of the nation’s efforts to combat the COVID-19 pandemic, the author of COVID-19 response roadmap, and co-author of a comprehensive set health policy strategies for COVID vaccines, testing, and treatments, Dr. McClellan and his Duke-Margolis colleagues are now focused on health policy strategies and solutions to advance the resilience and interconnectedness of 21^st Century public health and health care . Mark is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. Dr. McClellan is an independent board member on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and serves as an advisor for Arsenal Capital Group, Blackstone Life Sciences.

Marilyn B. Tavenner has served as a director of Select since November 2018. From August 2015 to June 2018, Ms. Tavenner served as the President and Chief Executive Officer of America’s Health Insurance Plans. From May 2013 to February 2015, she served as Administrator of the Centers for Medicare & Medicaid Services (“CMS”) under the Obama Administration. She joined CMS in 2010 and was appointed as its Acting Administrator in 2011. Prior to her tenure at CMS, Ms. Tavenner served as the Secretary of Health and Human Resources for the Commonwealth of Virginia and as a senior executive of the Hospital Corporation of America, Chippenham Medical Center and Johnston-Willis Hospital. Ms. Tavenner also serves as a director of Psychiatric Medical Care, LLC and Blue Cross Blue Shield of Arizona. Ms. Tavenner received her Bachelor of Science in Nursing and Master of Health Administration degrees from Virginia Commonwealth University.

Nancy-Ann DeParle is Managing Partner and Co-Founder, Consonance Capital Partners, and Former Assistant to the President and Deputy Chief of Staff for Policy to President Barack Obama

Nancy-Ann DeParle is a managing partner and co-founder of Consonance Capital Partners, a private equity firm that focuses on investing in the U.S. health care industry. She is a director of CVS Health (NYSE: CVS) and HCA Healthcare (NYSE: HCA), in addition to current Consonance portfolio companies Embark Behavioral Health, Priority OnDemand, Psychiatric Medical Care (PMC), and Sellers Dorsey.  She is also a member of the Duke University Board of Trustees and the National Academy of Medicine, and co-chairs the Advisory Board for the Stanford Department of Health Policy. 

From 2011-January 2013, DeParle was Assistant to the President and Deputy Chief of Staff for Policy to President Barack Obama.  A health policy expert, DeParle served as Counselor to the President and Director of the White House Office of Health Reform from 2009-2011, where she spearheaded President Obama’s successful effort to enact the Affordable Care Act (ACA) and managed the initial implementation of the law.

After leaving the White House, DeParle was a Lecturer in Law at Harvard Law School and a Visiting Scholar in Economic Studies at the Brookings Institution. From 2006-2009, she was a Managing Director of CCMP Capital Advisors, a senior advisor at JPMorgan Partners, and an Adjunct Professor of Health Systems at the Wharton School of the University of Pennsylvania.  She also served as a commissioner of the Medicare Payment Advisory Commission (MedPAC), which advises Congress on Medicare policy matters. 

Earlier in her career, DeParle served in the Clinton Administration as Administrator of the Centers for Medicare & Medicaid Services (CMS), and as Associate Director for Health & Personnel at the White House Office of Management & Budget (OMB).  She headed the Tennessee Department of Human Services and also worked as a lawyer in private practice in Nashville and Washington, D.C. 

DeParle received a B.A. with highest honors from the University of Tennessee, where she was Student Body President, and a J.D. from Harvard Law School.  She also received a B.A. and M.A. in Politics and Economics from Balliol College of Oxford University, where she was a Rhodes Scholar.